miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

@inproceedings{Wang2017miR6293pMS,
  title={miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer},
  author={Jin Wang and Cailu Song and Hailin Tang and Chao Zhang and Jun Tang and Xing Li and Bo Chen and Xiaoming Xie},
  booktitle={Breast Cancer Research},
  year={2017}
}
Different breast cancer subtypes show distinct tropisms for sites of metastasis. Notably, the lung is the most common site for the first distant recurrence in triple-negative breast cancer (TNBC). The identification of novel biomarkers for lung metastasis is of great importance to improving the outcome of TNBC. In this study, we sought to identify a microRNA (miRNA)-based biomarker and therapeutic target for lung metastasis of TNBC. A total of 669 patients without de novo stage IV TNBC were… CONTINUE READING